Gounaris Ioannis, Brenton James D
Cancer Research UK Cambridge Institute, Robinson Way, Cambridge, CB2 0RE, UK.
Future Oncol. 2015;11(9):1389-405. doi: 10.2217/fon.15.45.
Ovarian clear cell carcinoma is a distinct subtype of epithelial ovarian cancer, characterized by an association with endometriosis, glycogen accumulation and resistance to chemotherapy. Key driver events, including ARID1A mutations and HNF1B overexpression, have been recently identified and their functional characterization is ongoing. Additionally, the role of glycogen in promoting the malignant phenotype is coming under scrutiny. Appreciation of the notion that ovarian clear cell carcinoma is essentially an ectopic uterine cancer will hopefully lead to improved animal models of the disease, in turn paving the way for effective treatments.
卵巢透明细胞癌是上皮性卵巢癌的一种独特亚型,其特征是与子宫内膜异位症、糖原积累及化疗耐药相关。包括ARID1A突变和HNF1B过表达在内的关键驱动事件最近已被确定,对其功能特性的研究正在进行。此外,糖原在促进恶性表型方面的作用也在受到审视。认识到卵巢透明细胞癌本质上是一种异位性子宫癌这一观点,有望带来该疾病更好的动物模型,进而为有效治疗铺平道路。